Diagnosis and management of insulinoma

World Journal of Gastroenterology

Volumn 19, Issue 6, 2013, Pages 829-837

  Okabayashi, Takehiro ^a   Shima, Yasuo ^a   Sumiyoshi, Tatsuaki ^a   Kozuki, Akihito ^a   Ito, Satoshi ^b   Ogawa, Yasuhiro ^b   Kobayashi, Michiya ^b   Hanazaki, Kazuhiro ^b  

^a Kochi Health Sciences Center   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Continuous blood glucose monitoring; Diagnosis; Insulinoma; Management; Neuroendocrine pancreatic tumor; Pancreas

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; OCTREOTIDE; PROINSULIN;

ANGIOGRAPHY; ARTIFICIAL EMBOLISM; BLOOD GLUCOSE MONITORING; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; ENDOSCOPIC ECHOGRAPHY; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; HYPOGLYCEMIA; INSULINOMA; LYMPH NODE DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PALPATION; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; REVIEW; SENSITIVITY AND SPECIFICITY; TUMOR LOCALIZATION;

EID: 84873707976     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i6.829     Document Type: Review

References (86)

1. Moldow RE, Connelly RR. Epidemiology of pancreatic cancer in Connecticut. Gastroenterology 1968; 55: 677-686. [PMID: 4302500]
2. Service FJ, McMahon MM, O'Brien PC, Ballard DJ. Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 1991; 66: 711-719. [PMID: 1677058]
3. Kimura W, Kuroda A, Morioka Y. Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases. Dig Dis Sci 1991; 36: 933-942. [PMID: 2070707 DOI: 10.1007/BF01297144]
4. Lam KY, Lo CY. Pancreatic endocrine tumour: a 22-year clinico-pathological experience with morphological, immunohistochemical observation and a review of the literature. Eur J Surg Oncol 1997; 23: 36-42. [PMID: 9066745 DOI: 10.1016/S0748-7983(97)80140-0]
5. Eriksson B, Oberg K. Neuroendocrine tumours of the pancreas. Br J Surg 2000; 87: 129-131. [PMID: 10671915 DOI: 10.1046/j.1365-2168.2000.01277.x]
6. Gumbs AA, Moore PS, Falconi M, Bassi C, Beghelli S, Modlin I, Scarpa A. Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms. J Surg Oncol 2002; 81: 45-53; discussion 54. [PMID: 12210027 DOI: 10.1002/jso.10142]
7. Mansour JC, Chen H. Pancreatic endocrine tumors. J Surg Res 2004; 120: 139-161. [PMID: 15172200 DOI: 10.1016/ j.jss.2003.12.007]
8. Oberg K, Eriksson B. Endocrine tumours of the pancreas. Best Pract Res Clin Gastroenterol 2005; 19: 753-781. [PMID: 16253899 DOI: 10.1016/j.bpg.2005.06.002]
9. Chang F, Chandra A, Culora G, Mahadeva U, Meenan J, Herbert A. Cytologic diagnosis of pancreatic endocrine tumors by endoscopic ultrasound-guided fine-needle aspiration: a review. Diagn Cytopathol 2006; 34: 649-658. [PMID: 16900463 DOI: 10.1002/dc.20503]
10. Sotoudehmanesh R, Hedayat A, Shirazian N, Shahraeeni S, Ainechi S, Zeinali F, Kolahdoozan S. Endoscopic ultrasonography (EUS) in the localization of insulinoma. Endocrine 2007; 31: 238-241. [PMID: 17906369 DOI: 10.1007/ s12020-007-0045-4]
11. Doi R, Komoto I, Nakamura Y, Kawamura J, Fujimoto K, Wada M, Saga T, Imamura M. Pancreatic endocrine tumor in Japan. Pancreas 2004; 28: 247-252. [PMID: 15084965 DOI: 10.1097/00006676-200404000-00006]
12. Mittendorf EA, Liu YC, McHenry CR. Giant insulinoma: case report and review of the literature. J Clin Endocrinol Metab 2005; 90: 575-580. [PMID: 15522939 DOI: 10.1210/ jc.2004-0825]
13. Kondo T, Tomita S, Adachi H, Motoshima H, Taketa K, Matsuyoshi A, Tokunaga H, Miyamura N, Araki E. A case of hyperinsulinemia of undetermined origin, successfully treated with long-acting octreotide. Endocr J 2005; 52: 511-517. [PMID: 16284426 DOI: 10.1507/endocrj.52.511]
14. Chatziioannou A, Kehagias D, Mourikis D, Antoniou A, Limouris G, Kaponis A, Kavatzas N, Tseleni S, Vlachos L. Imaging and localization of pancreatic insulinomas. Clin Imaging 2001; 25: 275-283. [PMID: 11566091 DOI: 10.1016/ S0899-7071(01)00290-X]
15. Sheth S, Hruban RK, Fishman EK. Helical CT of islet cell tumors of the pancreas: typical and atypical manifestations. AJR Am J Roentgenol 2002; 179: 725-730. [PMID: 12185053]
16. Noone TC, Hosey J, Firat Z, Semelka RC. Imaging and localization of islet-cell tumours of the pancreas on CT and MRI. Best Pract Res Clin Endocrinol Metab 2005; 19: 195-211. [PMID: 15763695 DOI: 10.1016/j.beem.2004.11.013]
17. Owen NJ, Sohaib SA, Peppercorn PD, Monson JP, Grossman AB, Besser GM, Reznek RH. MRI of pancreatic neuroendocrine tumours. Br J Radiol 2001; 74: 968-973. [PMID: 11675319]
18. Thoeni RF, Mueller-Lisse UG, Chan R, Do NK, Shyn PB. Detection of small, functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity. Radiology 2000; 214: 483-490. [PMID: 10671597]
19. Anaye A, Mathieu A, Closset J, Bali MA, Metens T, Matos C. Successful preoperative localization of a small pancreatic insulinoma by diffusion-weighted MRI. JOP 2009; 10: 528-531. [PMID: 19734630]
20. Kann PH, Ivan D, Pfützner A, Forst T, Langer P, Schaefer S. Preoperative diagnosis of insulinoma: low body mass index, young age, and female gender are associated with negative imaging by endoscopic ultrasound. Eur J Endocrinol 2007; 157: 209-213. [PMID: 17656600 DOI: 10.1530/EJE-07-0117]
21. McLean AM, Fairclough PD. Endoscopic ultrasound in the localisation of pancreatic islet cell tumours. Best Pract Res Clin Endocrinol Metab 2005; 19: 177-193. [PMID: 15763694 DOI: 10.1016/j.beem.2004.11.012]
22. Kann PH, Rothmund M, Zielke A. Endoscopic ultrasound imaging of insulinomas: limitations and clinical relevance. Exp Clin Endocrinol Diabetes 2005; 113: 471-474. [PMID: 16151982 DOI: 10.1055/s-2005-865752]
23. Tseng LM, Chen JY, Won JG, Tseng HS, Yang AH, Wang SE, Lee CH. The role of intra-arterial calcium stimulation test with hepatic venous sampling (IACS) in the management of occult insulinomas. Ann Surg Oncol 2007; 14: 2121-2127. [PMID: 17431724 DOI: 10.1245/s10434-007-9398-4]
24. Morita S, Machida H, Kuwatsuru R, Saito N, Suzuki K, Iihara M, Obara T, Mitsuhashi N. Preoperative localization of pancreatic insulinoma by super selective arterial stimulation with venous sampling. Abdom Imaging 2007; 32: 126-128. [PMID: 16932851 DOI: 10.1007/s00261-006-9040-0]
25. Guettier JM, Kam A, Chang R, Skarulis MC, Cochran C, Alexander HR, Libutti SK, Pingpank JF, Gorden P. Localization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: the NIH experience. J Clin Endocrinol Metab 2009; 94: 1074-1080. [PMID: 19190102 DOI: 10.1210/ jc.2008-1986]
26. Chung JC, Choi SH, Jo SH, Heo JS, Choi DW, Kim YI. Localization and surgical treatment of the pancreatic insulinomas. ANZ J Surg 2006; 76: 1051-1055. [PMID: 17199688 DOI: 10.1111/j.1445-2197.2006.03947.x]
27. Jackson JE. Angiography and arterial stimulation venous sampling in the localization of pancreatic neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 2005; 19: 229-239. [PMID: 15763697 DOI: 10.1016/j.beem.2004.10.002]
28. Gimm O, König E, Thanh PN, Brauckhoff M, Karges W, Dralle H. Intra-operative quick insulin assay to confirm complete resection of insulinomas guided by selective arterial calcium injection (SACI). Langenbecks Arch Surg 2007; 392: 679-684. [PMID: 17294212 DOI: 10.1007/s00423-006-0144-3]
29. Wong M, Isa SH, Zahiah M, Azmi KN. Intraoperative ultrasound with palpation is still superior to intra-arterial calcium stimulation test in localising insulinoma. World J Surg 2007; 31: 586-592. [PMID: 17322973 DOI: 10.1007/ s00268-006-0106-5]
30. Hashimoto LA, Walsh RM. Preoperative localization of insulinomas is not necessary. J Am Coll Surg 1999; 189: 368-373. [PMID: 10509462 DOI: 10.1016/S1072-7515(99)00163-5]
31. Shin LK, Brant-Zawadzki G, Kamaya A, Jeffrey RB. Intraoperative ultrasound of the pancreas. Ultrasound Q 2009; 25: 39-48; quiz 48. [PMID: 19276960 DOI: 10.1097/RUQ.0b013e3181901ce4]
32. Ravi K, Britton BJ. Surgical approach to insulinomas: are pre-operative localisation tests necessary? Ann R Coll Surg Engl 2007; 89: 212-217. [PMID: 17394700 DOI: 10.1308/00358 8407X179008]
33. Kalafat H, Mihmanli I, Saribeyoglu K, Belli A. Intraoperative doppler ultrasound: a reliable diagnostic method in insulinoma. Hepatogastroenterology 2007; 54: 1256-1258. [PMID: 17629082]
34. Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes 2005; 54: 3592-3601. [PMID: 16306382 DOI: 10.2337/ diabetes.54.12.3592]
35. Suzuki K, Miyamoto M, Miyamoto T, Hirata K. Insulinoma with early-morning abnormal behavior. Intern Med 2007; 46: 405-408. [PMID: 17409607 DOI: 10.2169/internalmedicine.46.6071]
36. Service FJ. Hypoglycemic disorders. N Engl J Med 1995; 332: 1144-1152. [PMID: 7700289 DOI: 10.1056/NEJM199504273321707]
37. de Herder WW, Niederle B, Scoazec JY, Pauwels S, Kloppel G, Falconi M, Kwekkeboom DJ, Oberg K, Eriksson B, Wiedenmann B, Rindi G, O'Toole D, Ferone D. Welldifferentiated pancreatic tumor/carcinoma: insulinoma. Neuroendocrinology 2006; 84: 183-188. [PMID: 17312378 DOI: 10.1159/000098010]
38. Rostambeigi N, Thompson GB. What should be done in an operating room when an insulinoma cannot be found? Clin Endocrinol (Oxf) 2009; 70: 512-515. [PMID: 19170712 DOI: 10.1111/j.1365-2265.2009.03527.x]
39. Service FJ, Natt N. The prolonged fast. J Clin Endocrinol Metab 2000; 85: 3973-3974. [PMID: 11095416 DOI: 10.1210/ jc.85.11.3973]
40. Lebowitz MR, Blumenthal SA. The molar ratio of insulin to C-peptide. An aid to the diagnosis of hypoglycemia due to surreptitious (or inadvertent) insulin administration. Arch Intern Med 1993; 153: 650-655. [PMID: 8439228 DOI: 10.1001/ archinte.1993.00410050082011]
41. van Bon AC, Benhadi N, Endert E, Fliers E, Wiersinga WM. Evaluation of endocrine tests. D: the prolonged fasting test for insulinoma. Neth J Med 2009; 67: 274-278. [PMID: 19687521]
42. Vezzosi D, Bennet A, Fauvel J, Caron P. Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism. Eur J Endocrinol 2007; 157: 75-83. [PMID: 17609405 DOI: 10.1530/EJE-07-0109]
43. Hirshberg B, Livi A, Bartlett DL, Libutti SK, Alexander HR, Doppman JL, Skarulis MC, Gorden P. Forty-eight-hour fast: the diagnostic test for insulinoma. J Clin Endocrinol Metab 2000; 85: 3222-3226. [PMID: 10999812 DOI: 10.1210/ jc.85.9.3222]
44. Marks V. Recognition and differential diagnosis of spontaneous hypoglycaemia. Clin Endocrinol (Oxf) 1992; 37: 309-316. [PMID: 1483286 DOI: 10.1111/j.1365-2265.1992.tb02329.x]
45. Kar P, Price P, Sawers S, Bhattacharya S, Reznek RH, Grossman AB. Insulinomas may present with normoglycemia after prolonged fasting but glucose-stimulated hypoglycemia. J Clin Endocrinol Metab 2006; 91: 4733-4736. [PMID: 17003090 DOI: 10.1210/jc.2006-1430]
46. Goh BK, Ooi LL, Cheow PC, Tan YM, Ong HS, Chung YF, Chow PK, Wong WK, Soo KC. Accurate preoperative localization of insulinomas avoids the need for blind resection and reoperation: analysis of a single institution experience with 17 surgically treated tumors over 19 years. J Gastrointest Surg 2009; 13: 1071-1077. [PMID: 19291334 DOI: 10.1007/ s11605-009-0858-y]
47. Lo CY, Lam KY, Kung AW, Lam KS, Tung PH, Fan ST. Pancreatic insulinomas. A 15-year experience. Arch Surg 1997; 132: 926-930. [PMID: 9267281 DOI: 10.1001/archsurg.1997.01430320128023]
48. Tucker ON, Crotty PL, Conlon KC. The management of insulinoma. Br J Surg 2006; 93: 264-275. [PMID: 16498592 DOI: 10.1002/bjs.5280]
49. McAuley G, Delaney H, Colville J, Lyburn I, Worsley D, Govender P, Torreggiani WC. Multimodality preoperative imaging of pancreatic insulinomas. Clin Radiol 2005; 60: 1039-1050. [PMID: 16179163 DOI: 10.1016/j.crad.2005.06.005]
50. Balci NC, Semelka RC. Radiologic features of cystic, endocrine and other pancreatic neoplasms. Eur J Radiol 2001; 38: 113-119. [PMID: 11335093 DOI: 10.1016/S0720048X(01)00296-0]
51. Kurosaki Y, Kuramoto K, Itai Y. Hyperattenuating insulinoma at unenhanced CT. Abdom Imaging 1996; 21: 334-336. [PMID: 8661578 DOI: 10.1007/s002619900076]
52. Gouya H, Vignaux O, Augui J, Dousset B, Palazzo L, Louvel A, Chaussade S, Legmann P. CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas. AJR Am J Roentgenol 2003; 181: 987-992. [PMID: 14500214]
53. Davì MV, Falconi M. Pancreas: Insulinoma--new insights into an old disease. Nat Rev Endocrinol 2009; 5: 300-302. [PMID: 19465896 DOI: 10.1038/nrendo.2009.99]
54. Ritzel RA, Isermann B, Schilling T, Knaebel HP, Büchler MW, Nawroth PP. Diagnosis and localization of insulinoma after negative laparotomy by hyperinsulinemic, hypoglycemic clamp and intra-arterial calcium stimulation. Rev Diabet Stud 2004; 1: 42-46. [PMID: 17491664 DOI: 10.1900/ RDS.2004.1.42]
55. Rott G, Biggemann M, Pfohl M. Embolization of an insulinoma of the pancreas with trisacryl gelatin microspheres as definitive treatment. Cardiovasc Intervent Radiol 2008; 31: 659-662. [PMID: 17922161 DOI: 10.1007/s00270-007-9185-4]
56. Jürgensen C, Schuppan D, Neser F, Ernstberger J, Junghans U, Stölzel U. EUS-guided alcohol ablation of an insulinoma. Gastrointest Endosc 2006; 63: 1059-1062. [PMID: 16733126 DOI: 10.1016/j.gie.2005.10.034]
57. Limmer S, Huppert PE, Juette V, Lenhart A, Welte M, Wietholtz H. Radiofrequency ablation of solitary pancreatic insulinoma in a patient with episodes of severe hypoglycemia. Eur J Gastroenterol Hepatol 2009; 21: 1097-1101. [PMID: 19685572 DOI: 10.1097/MEG.0b013e328323d70e]
58. Gillams A, Cassoni A, Conway G, Lees W. Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience. Abdom Imaging 2005; 30: 435-441. [PMID: 15759207 DOI: 10.1007/s00261-004-0258-4]
59. Vezzosi D, Bennet A, Courbon F, Caron P. Shortand longterm somatostatin analogue treatment in patients with hypoglycaemia related to endogenous hyperinsulinism. Clin Endocrinol (Oxf) 2008; 68: 904-911. [PMID: 18031316 DOI: 10.1111/j.1365-2265.2007.03136.x]
60. Kishikawa H, Okada Y, Hirose A, Tanikawa T, Kanda K, Tanaka Y. Successful treatment of insulinoma by a single daily dose of octreotide in two elderly female patients. Endocr J 2006; 53: 79-85. [PMID: 16543676 DOI: 10.1507/endocrj.53.79]
61. Katabami T, Kato H, Shirai N, Naito S, Saito N. Successful long-term treatment with once-daily injection of low-dose octreotide in an aged patient with insulinoma. Endocr J 2005; 52: 629-634. [PMID: 16284444 DOI: 10.1507/endocrj.52.629]
62. Falconi M, Bettini R, Boninsegna L, Crippa S, Butturini G, Pederzoli P. Surgical strategy in the treatment of pancreatic neuroendocrine tumors. JOP 2006; 7: 150-156. [PMID: 16407638]
63. España-Gómez MN, Velázquez-Fernández D, Bezaury P, Sierra M, Pantoja JP, Herrera MF. Pancreatic insulinoma: a surgical experience. World J Surg 2009; 33: 1966-1970. [PMID: 19629581 DOI: 10.1007/s00268-009-0145-9]
64. Okabayashi T, Maeda H, Nishimori I, Sugimoto T, Ikeno T, Hanazaki K. Pancreatic fistula formation after pancreaticooduodenectomy; for prevention of this deep surgical site infection after pancreatic surgery. Hepatogastroenterology 2009; 56: 519-523. [PMID: 19579634]
65. Okabayashi T, Kobayashi M, Nishimori I, Sugimoto T, Onishi S, Hanazaki K. Risk factors, predictors and prevention of pancreatic fistula formation after pancreatoduodenectomy. J Hepatobiliary Pancreat Surg 2007; 14: 557-563. [PMID: 18040620 DOI: 10.1007/s00534-007-1242-5]
66. Okabayashi T, Hanazaki K, Nishimori I, Sugimoto T, Yoshioka R, Dabanaka K, Kobayashi M, Onishi S. Pancreatic transection using a sharp hook-shaped ultrasonically activated scalpel. Langenbecks Arch Surg 2008; 393: 1005-1008. [PMID: 17973117 DOI: 10.1007/s00423-007-0236-8]
67. Moore TJ, Peterson LM, Harrington DP, Smith RJ. Successful arterial embolization of an insulinoma. JAMA 1982; 248: 1353-1355. [PMID: 6287050 DOI: 10.1001/jama.1982.0333011 0049026]
68. Uflacker R. Arterial embolization as definitive treatment for benign insulinoma of the pancreas. J Vasc Interv Radiol 1992; 3: 639-644; discussion 644-646. [PMID: 1446125 DOI: 10.1016/S1051-0443(92)72912-1]
69. Shojamanesh H, Gibril F, Louie A, Ojeaburu JV, Bashir S, Abou-Saif A, Jensen RT. Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma. Cancer 2002; 94: 331-343. [PMID: 11900219 DOI: 10.1002/cncr.10195]
70. Oberg K, Kvols L, Caplin M, Delle Fave G, de Herder W, Rindi G, Ruszniewski P, Woltering EA, Wiedenmann B. Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Ann Oncol 2004; 15: 966-973. [PMID: 15151956 DOI: 10.1093/annonc/mdh216]
71. Healy ML, Dawson SJ, Murray RM, Zalcberg J, Jefford M. Severe hypoglycaemia after long-acting octreotide in a patient with an unrecognized malignant insulinoma. Intern Med J 2007; 37: 406-409. [PMID: 17535385 DOI: 10.1111/ j.1445-5994.2007.01371.x]
72. Grant CS. Insulinoma. Best Pract Res Clin Gastroenterol 2005; 19: 783-798. [PMID: 16253900 DOI: 10.1016/j.bpg.2005.05.008]
73. Hirshberg B, Cochran C, Skarulis MC, Libutti SK, Alexander HR, Wood BJ, Chang R, Kleiner DE, Gorden P. Malignant insulinoma: spectrum of unusual clinical features. Cancer 2005; 104: 264-272. [PMID: 15937909 DOI: 10.1002/ cncr.21179]
74. La Rosa S, Klersy C, Uccella S, Dainese L, Albarello L, Sonzogni A, Doglioni C, Capella C, Solcia E. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. Hum Pathol 2009; 40: 30-40. [PMID: 18715612 DOI: 10.1016/j.humpath.2008.06.005]
75. Scott A, Hinwood D, Donnelly R. Radio-frequency ablation for symptom control in a patient with metastatic pancreatic insulinoma. Clin Endocrinol (Oxf) 2002; 56: 557-559. [PMID: 11966750 DOI: 10.1046/j.1365-2265.2002.01506.x]
76. Le Treut YP, Delpero JR, Dousset B, Cherqui D, Segol P, Mantion G, Hannoun L, Benhamou G, Launois B, Boillot O, Domergue J, Bismuth H. Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report. Ann Surg 1997; 225: 355-364. [PMID: 9114793 DOI: 10.1097/00000658-199704000-00003]
77. Olausson M, Friman S, Cahlin C, Nilsson O, Jansson S, Wängberg B, Ahlman H. Indications and results of liver transplantation in patients with neuroendocrine tumors. World J Surg 2002; 26: 998-1004. [PMID: 12016481 DOI: 10.1007/s00268-002-6631-y]
78. Sawyer AM, Schade DS. Use of a continuous glucose monitor in the management of inoperable metastatic insulinoma: a case report. Endocr Pract 2008; 14: 880-883. [PMID: 18996817]
79. Munir A, Choudhary P, Harrison B, Heller S, Newell-Price J. Continuous glucose monitoring in patients with insulinoma. Clin Endocrinol (Oxf) 2008; 68: 912-918. [PMID: 18088393 DOI: 10.1111/j.1365-2265.2007.03161.x]
80. Yamashita K, Okabayashi T, Yokoyama T, Yatabe T, Maeda H, Manabe M, Hanazaki K. The accuracy of a continuous blood glucose monitor during surgery. Anesth Analg 2008; 106: 160-163, table of contents. [PMID: 18165572 DOI: 10.1213/01.ane.0000296461.26492.3c]
81. Yamashita K, Okabayashi T, Yokoyama T, Yatabe T, Maeda H, Manabe M, Hanazaki K. Accuracy and reliability of continuous blood glucose monitor in post-surgical patients. Acta Anaesthesiol Scand 2009; 53: 66-71. [PMID: 19032568 DOI: 10.1111/j.1399-6576.2008.01799.x]
82. Hanazaki K, Nosé Y, Brunicardi FC. Artificial endocrine pancreas. J Am Coll Surg 2001; 193: 310-322. [PMID: 11548802 DOI: 10.1016/S1072-7515(01)01014-6]
83. Okabayashi T, Hnazaki K, Nishimori I, Sugimoto T, Maeda H, Yatabe T, Dabanaka K, Kobayashi M, Yamashita K. Continuous post-operative blood glucose monitoring and control using a closed-loop system in patients undergoing hepatic resection. Dig Dis Sci 2008; 53: 1405-1410. [PMID: 17934862 DOI: 10.1007/s10620-007-0010-3]
84. Okabayashi T, Nishimori I, Yamashita K, Sugimoto T, Maeda H, Yatabe T, Kohsaki T, Kobayashi M, Hanazaki K. Continuous postoperative blood glucose monitoring and control by artificial pancreas in patients having pancreatic resection: a prospective randomized clinical trial. Arch Surg 2009; 144: 933-937. [PMID: 19841361 DOI: 10.1001/archsurg.2009.176]
85. Okabayashi T, Nishimori I, Maeda H, Yamashita K, Yatabe T, Hanazaki K. Effect of intensive insulin therapy using a closed-loop glycemic control system in hepatic resection patients: a prospective randomized clinical trial. Diabetes Care 2009; 32: 1425-1427. [PMID: 19435954 DOI: 10.2337/dc08-2107]
86. Okabayashi T, Nishimori I, Yamashita K, Sugimoto T, Yatabe T, Maeda H, Kobayashi M, Hanazaki K. Risk factors and predictors for surgical site infection after hepatic resection. J Hosp Infect 2009; 73: 47-53. [PMID: 19640610 DOI: 10.1016/j.jhin.2009.04.022]